These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26707321)

  • 1. Efficacy and Safety of Bisphosphonates for Osteoporosis or Osteopenia in Cardiac Transplant Patients: A Meta-Analysis.
    Zhao J; Wang C; Hu Z
    Transplant Proc; 2015 Dec; 47(10):2957-64. PubMed ID: 26707321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.
    Wang J; Yao M; Xu JH; Shu B; Wang YJ; Cui XJ
    Osteoporos Int; 2016 May; 27(5):1683-90. PubMed ID: 26733377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly oral bisphosphonates over 2 years prevent bone loss in cardiac transplant patients.
    Lange U; Classen K; Müller-Ladner U; Richter M
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28940569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of bisphosphonates for osteoporosis or osteopenia in Crohn's disease: a meta-analysis.
    Guo Z; Wu R; Gong J; Zhu W; Li Y; Li N; Li J
    Dig Dis Sci; 2013 Apr; 58(4):915-22. PubMed ID: 23179146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates for osteoporosis in nonmetastatic prostate cancer patients receiving androgen-deprivation therapy: a systematic review and meta-analysis.
    Ding H; Yang L; Du W; Teng Y; Fu SJ; Tao Y; Lu JZ; Wang ZP
    Asian Pac J Cancer Prev; 2013; 14(5):3337-43. PubMed ID: 23803126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bisphosphonates on bone loss in the first year after renal transplantation--a meta-analysis of randomized controlled trials.
    Mitterbauer C; Schwarz C; Haas M; Oberbauer R
    Nephrol Dial Transplant; 2006 Aug; 21(8):2275-81. PubMed ID: 16574684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
    Chen L; Wang G; Zheng F; Zhao H; Li H
    Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review.
    Melek J; Sakuraba A
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):32-44.e5. PubMed ID: 23981521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bisphosphonates on bone mineral density in liver transplant patients: a meta-analysis and systematic review of randomized controlled trials.
    Kasturi KS; Chennareddygari S; Mummadi RR
    Transpl Int; 2010 Feb; 23(2):200-7. PubMed ID: 19793074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bisphosphonates on long-term kidney transplantation outcomes.
    Song SH; Choi HY; Kim HY; Nam CM; Jeong HJ; Kim MS; Kim SII; Kim YS; Huh KH; Kim BS
    Nephrol Dial Transplant; 2021 Mar; 36(4):722-729. PubMed ID: 33367861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone density in heart or lung transplant recipients--a longitudinal study.
    Wang TK; O'Sullivan S; Gamble GD; Ruygrok PN
    Transplant Proc; 2013; 45(6):2357-65. PubMed ID: 23747143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bisphosphonates on bone mineral density and fracture prevention in gastric cancer patients after gastrectomy.
    Lim JS; Jin SH; Kim SB; Lee JI
    J Clin Gastroenterol; 2012 Sep; 46(8):669-74. PubMed ID: 22504799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis.
    Kan SL; Ning GZ; Chen LX; Zhou Y; Sun JC; Feng SQ
    Medicine (Baltimore); 2016 Feb; 95(5):e2679. PubMed ID: 26844505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-head comparisons of bisphosphonates and teriparatide in osteoporosis: a meta-analysis.
    Liu CL; Lee HC; Chen CC; Cho DY
    Clin Invest Med; 2017 Jun; 40(3):E146-E157. PubMed ID: 28653616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials.
    Lou S; Lv H; Li Z; Zhang L; Tang P
    BMJ Open; 2018 Mar; 8(3):e015187. PubMed ID: 29500198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
    Ito K; Blinder VS; Elkin EB
    J Clin Oncol; 2012 May; 30(13):1468-75. PubMed ID: 22370313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis.
    Kim MJ; Kim SN; Lee IS; Chung S; Lee J; Yang Y; Lee I; Koh SE
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1343-50. PubMed ID: 26214607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis.
    Toth-Manikowski SM; Francis JM; Gautam A; Gordon CE
    Clin Transplant; 2016 Sep; 30(9):1090-6. PubMed ID: 27327448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there enough evidence to use bisphosphonates in HIV-infected patients? A systematic review and meta-analysis.
    Pinzone MR; Moreno S; Cacopardo B; Nunnari G
    AIDS Rev; 2014; 16(4):213-22. PubMed ID: 25300622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.